Loss of heterozygosity of key tumor suppressor genes in advanced renal cancer patients treated with nivolumab (vol 10, pg 743, 2018)

被引：0
|
作者：
Bersanelli, Melissa
Gnetti, Letizia
Azzoni, Cinzia
Bottarelli, Lorena
Sverzellati, Nicola
Campanini, Nicoletta
Varotti, Elena
Corrado, Michele
Parziale, Raffaele
Rapacchi, Elena
Caruso, Giuseppe
Leonardi, Francesco
Silini, Enrico Maria
Buti, Sebastiano
机构：
来源：
IMMUNOTHERAPY | 2018年 / 10卷 / 14期
关键词：
D O I：
10.2217/imt-2017-0160c1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1287 / 1288
页数：2
相关论文
共 50 条
  • [21] ROLE OF PRIMARY TUMOR IN ADVANCED RENAL CELL CARCINOMA (RCC) PATIENTS TREATED WITH NIVOLUMAB/IPILIMMUMAB OR CABOZANTINIB
    Ciccarese, Chiara
    Maruzzo, Marco
    Atzori, Francesco
    Galli, Luca
    Scagliarini, Sarah
    Massari, Francesco
    Verzoni, Elena
    Cannella, Maria Antonella
    Maratta, Maria Grazia
    Astore, Serena
    Caserta, Claudia
    Bimabatti, Davide
    Deppieri, Filippo Maria
    Dessi, Mariele
    Paolieri, Federico
    Riccardi, Ferdinando
    Bracarda, Sergio
    De Giorgi, Ugo
    Basso, Umberto
    Procopio, Giuseppe
    Tortora, Giampaolo
    ANTICANCER RESEARCH, 2021, 41 (10) : 5309 - 5312
  • [22] Rare loss of heterozygosity of the MTS1 and MTS2 tumor suppressor genes in differentiated human thyroid cancer
    Schulte, KM
    Staudt, S
    Niederacher, D
    Finken-Eigen, M
    Köhrer, K
    Goretzki, PE
    Röher, HD
    HORMONE AND METABOLIC RESEARCH, 1998, 30 (09) : 549 - 554
  • [23] Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer
    Friedrich, MG
    Erbersdobler, A
    Schwaibold, H
    Conrad, S
    Huland, E
    Huland, H
    JOURNAL OF UROLOGY, 2000, 163 (03): : 1039 - 1042
  • [24] Safety and Efficacy of Nivolumab in Patients With Advanced Nonesmall-cell Lung Cancer Treated Beyond Progression (vol 20, pg 178, 2019)
    Ricciuti, Biagio
    Genova, Carlo
    Bassanelli, Maria
    De Giglio, Andrea
    Brambilla, Marta
    Metro, Giulio
    Baglivo, Sara
    Dal Bello, Maria Giovanna
    Ceribelli, Anna
    Grossi, Francesco
    Chiari, Rita
    CLINICAL LUNG CANCER, 2020, 21 (04) : E239 - E239
  • [25] Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas. (vol 57, pg 5009, 1997)
    Schwerdtle, RF
    Winterpacht, A
    Störkel, S
    Brenner, W
    Hohenfellner, R
    Zabel, B
    Huber, C
    Decker, HJ
    Störkel, S
    Brauch, H
    CANCER RESEARCH, 1999, 59 (08) : 2021 - 2021
  • [26] First-Line Paclitaxel and Carboplatin in Persistent/Recurrent or Advanced Cervical Cancer: A Retrospective Analysis of Patients Treated at Brazilian National Cancer Institute (vol 23, pg 743, 2013)
    Garces, A. H., I
    Ribeiro Mora, Paulo Alexandre
    de Melo, Andreia Cristina
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (05) : 978 - 978
  • [27] Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer (vol 74, pg 5631, 2014)
    Geng, Chuandong
    Rajapakshe, Kimal
    Shah, Shrijal S.
    Shou, John
    Eedunuri, Vijay Kumar
    Foley, Christopher
    Fiskus, Warren
    Rajendran, Mahitha
    Chew, Sue Anne
    Zimmermann, Martin
    Bond, Richard
    He, Bin
    Coarfa, Cristian
    Mitsiades, Nicholas
    CANCER RESEARCH, 2019, 79 (17) : 4552 - 4552
  • [28] Exploratory evaluation of baseline tumor biomarkers and their association with response and survival in patients with previously treated advanced gastric cancer treated with andecaliximab combined with nivolumab versus nivolumab.
    Metges, Jean-Philippe
    Elboudwarej, Emon
    Cunningham, David
    Catenacci, Daniel V. T.
    Van Cutsem, Eric
    Wainberg, Zev A.
    Zhang, Yafeng
    Turner, Scott
    Thai, Dung
    Bhargava, Pankaj
    Shah, Manish A.
    Brachmann, Carrie
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [29] CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer (vol 36, pg 2836, 2018)
    Janjigian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (05) : 443 - 443
  • [30] miR-199b-5p serves as a tumor suppressor in renal cell carcinoma (vol 16, pg 436, 2018)
    Lai, Yulin
    Quan, Jing
    Lin, Canbin
    Li, Hang
    Hu, Jia
    Chen, Peijie
    Xu, Jinling
    Guan, Xin
    Xu, Weijie
    Lai, Yongqing
    Ni, Liangchao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (02) : 1561 - 1561
12345